Therapeutic benefit of palmitoylethanolamide in the management of neuropathic pain
Background: Neuropathic pain is defined by International Association for the Study of Pain (IASP) as “Pain caused by a lesion or disease of the somatosensory nervous system”. Elderly patients generally have high incidence of chronic neuropathic pain. The safe and effective treatment for chronic pai...
Main Authors: | I. D. Chaurasia, Kunal Vinayak, Shashikant Tiwari, Prateek Malpani, Sheikh Behram, Mahim Koshariya |
---|---|
Format: | Article |
Language: | English |
Published: |
London Academic Publishing
2018-12-01
|
Series: | Romanian Neurosurgery |
Subjects: | |
Online Access: | https://www.journals.lapub.co.uk/index.php/roneurosurgery/article/view/1143 |
Similar Items
-
Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
by: Tai-Kyung Seol, et al.
Published: (2017-10-01) -
ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
by: Ramona D’Amico, et al.
Published: (2020-07-01) -
Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide
by: Alessia D’Aloia, et al.
Published: (2020-11-01) -
Effects of the glial modulator palmitoylethanolamide on chronic pain intensity and brain function
by: Alshelh Z, et al.
Published: (2019-08-01) -
Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review
by: Maria Beatrice Passavanti, et al.
Published: (2019-01-01)